The global Idiopathic Pulmonary Fibrosis (IPF) Market is estimated to be valued at US$ 3,853.6 million in 2022 and is expected to exhibit a CAGR of 8.7% over the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.
A) Market Overview:
Idiopathic Pulmonary Fibrosis is a rare and chronic lung disease that causes scarring and thickening of the lung tissue. The exact cause of IPF remains unknown, hence the name "idiopathic ... Read more
